Page last updated: 2024-10-31

moclobemide and Cirrhosis, Liver

moclobemide has been researched along with Cirrhosis, Liver in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
" From these studies it can be concluded that, pharmacokinetically, neither age nor renal impairment require adjusting the dosage of moclobemide."1.28Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function. ( Andressen, C; Frey, F; Guentert, TW; Mayersohn, M; Ohnhaus, EE; Pfefen, JP; Schoerlin, MP; Stoeckel, K, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stoeckel, K1
Pfefen, JP1
Mayersohn, M1
Schoerlin, MP1
Andressen, C1
Ohnhaus, EE1
Frey, F1
Guentert, TW1

Other Studies

1 other study available for moclobemide and Cirrhosis, Liver

ArticleYear
Absorption and disposition of moclobemide in patients with advanced age or reduced liver or kidney function.
    Acta psychiatrica Scandinavica. Supplementum, 1990, Volume: 360

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Female; Hum

1990